Newborn screening for tyrosinaemia type 1: Benefit unclear
Tyrosinaemia type 1 is a rare, hereditary metabolic disease that, if left untreated, can already lead to serious liver and kidney damage in infancy. The German Institute for Quality and Efficiency in Health Care investigated the benefit and harm of tandem mass spectrometry screening for tyrosinaemia type 1 in newborns.
Go to Source
